Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143,223,667
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
14,854,223
-
Shares change
-
+2,750,023
-
Total reported value, excl. options
-
$278,593,752
-
Value change
-
+$51,374,327
-
Put/Call ratio
-
0%
-
Number of buys
-
41
-
Number of sells
-
-18
-
Price
-
$18.76
Significant Holders of Applied Therapeutics, Inc. - Common Stock (APLT) as of Q1 2021
77 filings reported holding APLT - Applied Therapeutics, Inc. - Common Stock as of Q1 2021.
Applied Therapeutics, Inc. - Common Stock (APLT) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,854,223 shares
of 143,223,667 outstanding shares and own 10.37% of the company stock.
Largest 10 shareholders include FMR LLC (2,533,066 shares), ORBIMED ADVISORS LLC (2,257,387 shares), BlackRock Inc. (1,203,730 shares), ALKEON CAPITAL MANAGEMENT LLC (1,041,334 shares), Knoll Capital Management, LLC (1,025,464 shares), VANGUARD GROUP INC (834,091 shares), FRANKLIN RESOURCES INC (748,982 shares), Rock Springs Capital Management LP (701,680 shares), EMERALD MUTUAL FUND ADVISERS TRUST (644,572 shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (639,458 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.